March 24, 2016 Medidata , the world's leading provider of cloud science solutions for life sciences, announced today that the company's industry-leading technology platform has been awarded Shanghai Fuhong Hanlin Biotechnology Co., Ltd. (hereinafter referred to as “Fuhong Hanlin†)use. Fuhong Hanlin is committed to the development of monoclonal antibody drugs. The company uses the Medidata Clinical Cloud platform to conduct complex phase III oncology clinical trials in China to improve the efficiency of experimental research.
Dr. Liu Yin, Director of Clinical and Medical Department of Fuhong Hanlin, said: “To meet the complex requirements of the Fuhong Hanlin Phase III Oncology Institute and to continue to lead innovation to better serve patients, how to treat our treatment expertise Combined with cutting-edge technology in the industry, Medidata's powerful integrated technology platform provides our team with real-time information on clinical data and test runs, enabling us to better monitor trials and make faster decisions.†Shanghai Fuhong Hanlin Biotechnology Co., Ltd. was established in 2009 and is a joint venture between Shanghai Fosun Pharmaceutical (Group) and Hanlin Biopharmaceutical Company. The company is committed to the development and industrialization of monoclonal antibody generic drugs for a wide range of therapeutic areas, including cancer and autoimmune diseases. Fuhong Hanlin uses Medidata's integrated cloud technology solution for electronic data collection (Meddata Rave), randomized distribution and Medidata Balance to optimize trial runs and streamline workflow for Phase III oncology research.
Mr. Huang Guiping, Vice President of Operations, Asia Pacific, Medidata, said: "Medidata's cloud technology platform helps Fuhong Hanlin simplify research operations by providing integrated integrated systems for clinical electronic data collection, randomization and drug supply management. And more flexible mid-term research supply adjustments. Reduce costs and test risks and shorten overall time. We look forward to using Medidata's powerful technology to consolidate Fuhong Hanlin's deep therapeutic expertise to help its research team implement faster, more efficient, and More meaningful trials and ultimately more effective treatment for patients."
We are a professional Chinese supplier of Anti Uv Material; we supply various products of Anti-Radiation Materials; and we can providing product images and basic parameters with each Uv Protection Ingredients, and Sun Care Ingredients, such as phloretin, lutein, gingerol . Look forward to your cooperation!
Anti-radiation Materials,UV Protection Ingredients,Grape Skin Extract,Pomegranate Peel Extract,Apple Bark Extract
Xi'an Quanao Biotech Co., Ltd. , https://www.quanaobiotech.com